Cyclomedica News

First 40 patients’ milestone reached in USFDA Phase 3 Technegas study

29th Mar 2018

Continue Reading

Cyclopharm (ASX.CYC) Presentation, FNN Investor Event, Dec 2017, Sydney

20th Dec 2017

Continue Reading

CEO & MD, James McBrayer talks lung disease screening

19th Dec 2017

Continue Reading

Nuclear imaging trial aiming to clear up airway diagnosis

12th Oct 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading

Advancing Molecular Imaging in NSW

12th Oct 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading

USFDA Technegas Clinical Trial – Patient Enrolment Underway

28th Sep 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading

Cyclopharm Acquires European Distribution Business

12th Aug 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading